Peripheral Neuropathy Trial, Recruiting NCT07397117 Sponsor: University of California, San Francisco Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07397117
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have come to the emergency department with sudden or worsening pain that matches sciatica — meaning one-sided pain starting in the lower back or buttock area and travelling down the back of the leg, sometimes reaching below the knee
  • People whose pain rates at 5 out of 10 or higher on a pain scale

Who may not be able to join:

  • People with a known allergy to the study medications, such as local anaesthetics
  • People who have a blood clotting disorder or who are currently taking blood-thinning medications
  • People where a spinal infection or spinal tumour is suspected or confirmed
  • People with certain nerve-related symptoms such as loss of bladder or bowel control, or weakness in the legs
  • People who are not able to give their own informed consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jeanne Noble, MD, University of California, San Francisco

Phone: 628-247-7578

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 May 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov